Lifetime Omics stands at the forefront of global AI-based research in the life sciences, currently developing a pioneering technology that will provide unparalleled access to a vast network of health and omics data for researchers worldwide. Our FAIRLYZ technology will promote and facilitate collaborations with esteemed scientists across research institutions to spearhead the era of AI-based clinical decision support systems (CDSS) that provide diagnosis support, treatment planning, risk assessment, and disease prevention. This transformative era of AI/ML in healthcare will only succeed with reliable CDSS. CDSS must be trained with quality-controlled health data, including EHR, omics, imaging, and clinical trial data to be reliable. The evolution of CDSS in healthcare can be seen as a progressive continuum, commencing with smaller, focused studies conducted by laboratory scientists and culminating in the integration of wearable and sensor technology for real-time health monitoring and individualized treatment approaches. FAIRLYZ is building the foundation for this continuum by bridging collaboration gaps, generating diversified funding channels, enabling diverse analyses, and empowering researchers to drive scientific progress.